$1.140
-0.048 (-4.20%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
TELO 相似图表分析预测
Alphio's TELO stock price prediction model matches the current Telomir Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.16 (+1.85%). The 1-week path is $1.24 (+8.56%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 Telomir Pharmaceuticals Inc 股票吗？
Telomir Pharmaceuticals Inc (TELO) is currently trading at $1.14, which is below its 200-day simple moving average of $1.279. The stock has a relative strength index (RSI) of 46.462, indicating it is neither overbought nor oversold. However, the company has reported consistent losses, with a net income of -$47,835,431 in Q2 2026 and a negative EPS of -0.79. The forward P/E ratio is 0, indicating no earnings expected in the near term. The stock has seen a year-to-date change of -14.93%, suggesting a downward trend. The main risk is the significant net loss reported, which could impact future performance. Overall, while there are some signs of potential recovery, the current financial performance and negative earnings trend suggest it may be prudent to hold off on buying until further positive developments occur.
TELO 股价于 Friday 收于 $1.14，此前下跌 -4.20%
Telomir Pharmaceuticals Inc (TELO) last closed at $1.14, losing -4.20%. These facts feed the 1-day and 1-week TELO price prediction above.
预测驱动因素
Telomir Pharmaceuticals Inc（TELO）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
相似图表形态
近期走势与 TELO 最接近的股票，按相似度排序。
TELO 季节性分析
Historically the probability of a positive August return for TELO is 15.87%. January offers the highest probability of a positive month at 70.00%, while July is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
TELO 十年价格预测
| 月份 | 最低价 | 平均价 | 最高价 | 潜在回报率 |
|---|---|---|---|---|
| Aug 2026 | $2.31 | $2.69 | $2.89 | +136.29% |
| Sep 2026 | $2.49 | $2.65 | $2.82 | +132.57% |
| Oct 2026 | $2.12 | $2.57 | $2.59 | +125.43% |
| Nov 2026 | $1.88 | $2.30 | $2.68 | +101.82% |
| Dec 2026 | $1.78 | $2.03 | $2.35 | +78.50% |
2026 年，Telomir Pharmaceuticals Inc（TELO）预计区间为 $1.78 至 $2.89。
Telomir Pharmaceuticals Inc 2026 年月度预测
2026 年 Aug，Telomir Pharmaceuticals Inc 预计均价 $2.69，最低 $2.31，最高 $2.89。
2026 年 Sep，Telomir Pharmaceuticals Inc 预计均价 $2.65，最低 $2.49，最高 $2.82。
2026 年 Oct，Telomir Pharmaceuticals Inc 预计均价 $2.57，最低 $2.12，最高 $2.59。
2026 年 Nov，Telomir Pharmaceuticals Inc 预计均价 $2.30，最低 $1.88，最高 $2.68。
2026 年 Dec，Telomir Pharmaceuticals Inc 预计均价 $2.03，最低 $1.78，最高 $2.35。
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。